‘This Is a Life and Death Matter’: DEA Faces Tsunami of Criticism on Proposed Telehealth-Controlled Substances Rules

The two proposed rules from the Drug Enforcement Administration (DEA) that effectively undue controlled substances prescribing via telehealth have received over 21,000 submissions so far during its public comment period. And the overwhelming majority of those comments oppose the proposed rules as presented. The DEA released the proposed rules on Feb. 24. The proposed rules […]